Information received from healthcare provider via manufacturer representative regarding an event happened during intra-op for a patient undergoing unknown spinal therapy.The levels implanted were l4/5.The pre-op diagnosis was mentioned as spinal canal stenosis.It was reported that, the implant was damaged during insertion.Even though removal was performed, part of it remained in the body.They inserted a new cage without forcibly taking the remained part and the procedure was completed.The cage was broken.There were no plans to retrieve the broken piece of cage from patient body.The broken piece of cage remains in the intervertebral body.There was no additional treatment or surgery performed as a result of this event.There were no symptoms or complications to patient/physician reported.There was no health damage in patient was reported.No further complications reported.
|
H3: product analysis of part#4986050 ; lot# h5649504 analysis summary: a visual review of the returned implant identified that portions have been broken.Microscopic examination of the inserter interface identified damage to the threaded hole area and deformation on the top face, and fracture on one side around the inserter tang interface, consistent with significant impact and torsional loading.Microscopic examination of the fracture surface of the broken portions of the implant identified a fracture with rays emanating away from the area of crack initiation, consistent with brittle overload.The observations are consistent with impaction overload.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|